Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.449 USD | +0.34% | -6.22% | -57.25% |
Apr. 24 | Transcript : Evoke Pharma, Inc. - Special Call | |
Mar. 21 | Evoke Pharma, Inc. Announces Board Changes as of March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 14.08M | Sales 2025 * | 21.9M | Capitalization | 3.79M |
---|---|---|---|---|---|
Net income 2024 * | -3M | Net income 2025 * | 1M | EV / Sales 2024 * | 0.27 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.17 x |
P/E ratio 2024 * |
-1.95
x | P/E ratio 2025 * |
14.9
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.62% |
Latest transcript on Evoke Pharma, Inc.
1 day | -2.57% | ||
1 week | -6.22% | ||
Current month | -26.39% | ||
1 month | -23.90% | ||
3 months | -30.60% | ||
6 months | -64.65% | ||
Current year | -57.25% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 06-12-31 | |
Marilyn Carlson
CTO | Chief Tech/Sci/R&D Officer | 76 | 13-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cam L. Garner
FOU | Founder | 75 | 06-12-31 |
Kenneth Widder
BRD | Director/Board Member | 71 | 07-05-31 |
Todd Brady
BRD | Director/Board Member | 52 | 07-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.449 | +0.34% | 1 424 |
24-04-24 | 0.4475 | +0.90% | 9,015 |
24-04-23 | 0.4435 | -2.53% | 4,804 |
24-04-22 | 0.455 | -2.88% | 11,182 |
24-04-19 | 0.4685 | -2.15% | 1,943 |
Delayed Quote Nasdaq, April 25, 2024 at 10:50 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.25% | 3.79M | |
+24.17% | 562B | |
-6.51% | 358B | |
+18.34% | 322B | |
+7.27% | 297B | |
+13.43% | 219B | |
+6.13% | 199B | |
-10.35% | 196B | |
-11.24% | 149B | |
-7.02% | 146B |
- Stock Market
- Equities
- EVOK Stock